Skip to main content
. Author manuscript; available in PMC: 2010 Nov 8.
Published in final edited form as: Breast Cancer Res Treat. 2010 May 13;122(1):189–191. doi: 10.1007/s10549-010-0933-9

Table 1.

Potential mechanisms of ONJ [19]

Inhibition of bone remodeling Compromised bone microenvironment functioning affecting bone remodeling and repair
Vascular Antiangiogenic affects delaying wound healing and/or affecting micro-infarction in bone and/or soft tissues
Infection and inflammation Microorganisms of the oral cavity promoting cell death in the bone and/or oral soft tissues
Genetic predisposition Genetic polymorphisms affecting drug metabolism, excretion, or drug targets within pathways of bone metabolism and/or wound healing
Drug interactions Drug interactions between chemotherapy and bisphosphonate selectively promoting cell death